Note*: This report requires 5-10 business days to complete.
“Ulcerative Colitis (UC) - Market Insights, Epidemiology and Market Size Forecast-2020” report provides an overview of the disease and global market size of the Ulcerative Colitis (UC) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ulcerative Colitis (UC) from 2010-2020.Ulcerative colitis is a chronic disease of the large intestine, also known as the colon, in which the lining of the colon becomes inflamed and develops tiny open sores, or ulcers, that produce pus and mucous. Ulcerative colitis has an incidence of 1 to 20 cases per 100,000 individuals per year, and a prevalence of 8 to 246 per 100,000 individuals. Patients with proctitis or left-sided colitis usually have a more benign course: only 15% progress proximally with their disease, and up to 20% can have sustained remission in the absence of any therapy. Over a decade ago, treatment goals in ulcerative colitis (UC) focused mainly on achieving symptomatic remission. With new biologic agents, new treatment options for UC continue to evolve. Anti-TNF therapies such as the fully humanized monoclonal antibody adalimumab, PEGylated humanized Fab fragment certolizumab pegol, anti-IL-12 antibody and the granulocyte-macrophage colony stimulating factor sagramostim have been shown to be effective in CD. Randomized controlled trials of these drugs need to be conducted in UC patients.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Ulcerative Colitis (UC) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Non-Hodgkin’s Lymphoma (NHL)
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Ulcerative Colitis (UC)Market
• Global Epidemiology of Ulcerative Colitis (UC)Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Ulcerative Colitis (UC)Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Ulcerative Colitis (UC)(2011-2020)
• Table 7: Ulcerative Colitis (UC)Global Market Size (USD Millions), (2011-2014)
• Table 8: Ulcerative Colitis (UC)Global Market Size (USD Millions), (2015-2020)
• Table 9: Ulcerative Colitis (UC)US Market Size (USD Millions), (2011-2014)
• Table 10: Ulcerative Colitis (UC)US Market Size (USD Millions), (2015-2020)
• Table 11: Ulcerative Colitis (UC)United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Ulcerative Colitis (UC)Germany Market Size (USD Millions), (2015-2020)
• Table 13: Ulcerative Colitis (UC)United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Ulcerative Colitis (UC)United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Ulcerative Colitis (UC)France Market Size (USD Millions), (2011-2014)
• Table 16: Ulcerative Colitis (UC)France Market Size (USD Millions), (2015-2020)
• Table 17: Ulcerative Colitis (UC)Italy Market Size (USD Millions), (2011-2014)
• Table 18: Ulcerative Colitis (UC)Italy Market Size (USD Millions), (2015-2020)
• Table 19: Ulcerative Colitis (UC)Spain Market Size (USD Millions), (2011-2014)
• Table 20: Ulcerative Colitis (UC)Spain Market Size (USD Millions), (2015-2020)
• Table 21: Ulcerative Colitis (UC)Japan Market Size (USD Millions), (2011-2014)
• Table 22: Ulcerative Colitis (UC)Japan Market Size (USD Millions), (2015-2020)
• Table 23: Ulcerative Colitis (UC)ROW Market Size (USD Millions), (2011-2014)
• Table 24: Ulcerative Colitis (UC)ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Ulcerative Colitis (UC)Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Ulcerative Colitis (UC)(2011-2020)
• Figure 3: Ulcerative Colitis (UC)Global Market Size (USD Millions), (2011-2014)
• Figure 4: Ulcerative Colitis (UC)Global Market Size (USD Millions), (2015-2020)
• Figure 5: Ulcerative Colitis (UC)US Market Size (USD Millions), (2011-2014)
• Figure 6: Ulcerative Colitis (UC)US Market Size (USD Millions), (2015-2020)
• Figure 7: Ulcerative Colitis (UC)Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Ulcerative Colitis (UC)Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Ulcerative Colitis (UC)United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Ulcerative Colitis (UC)United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Ulcerative Colitis (UC)France Market Size (USD Millions), (2011-2014)
• Figure 12: Ulcerative Colitis (UC)France Market Size (USD Millions), (2015-2020)
• Figure 13: Ulcerative Colitis (UC)Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Ulcerative Colitis (UC)Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Ulcerative Colitis (UC)Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Ulcerative Colitis (UC)Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Ulcerative Colitis (UC)Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Ulcerative Colitis (UC)Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Ulcerative Colitis (UC)ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Ulcerative Colitis (UC)ROW Market Size (USD Millions), (2015-2020)
